Scapa (SCPA) will legally contest medical technology group ConvaTec’s (CTEC) decision to exit a “material” supply deal worth $30m (£23.8m) in annual revenues.
To continue reading, subscribe today
and enjoy unlimited access to the following:
- Tips of the Week
- Funds coverage
- Weekly features on big investment themes
- Trading ideas
- Comprehensive companies coverage
- Economic analysis
